Lista de obras -

A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers

artículo científico publicado en 2013

A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City

artículo científico publicado en 2020

A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior

scientific article published on 26 June 2019

A review of human drug self-administration procedures ⬇️

artículo científico publicado el 1 de septiembre de 2013

A review of pharmacogenetic studies of substance-related disorders

artículo científico publicado en 2015

Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount

artículo científico publicado en 2017

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

artículo científico publicado en 2014

Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone

scientific article published on 04 September 2019

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers

artículo científico publicado en 2012

Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users

artículo científico publicado en 2013

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone

artículo científico publicado en 2013

Can Naloxone Be Used to Treat Synthetic Cannabinoid Overdose?

artículo científico publicado en 2016

Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal

artículo científico publicado en 2019

Chronic pain and opioid abuse: Factors associated with health-related quality of life

artículo científico publicado en 2017

Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts

artículo científico publicado en 2013

Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.

artículo científico publicado en 2009

Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.

artículo científico publicado en 2009

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial

artículo científico publicado en 2017

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

artículo científico publicado en 2017

Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers

artículo científico publicado en 2013

Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers

artículo científico publicado en 2017

Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder

scientific article published on 17 January 2020

Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis

artículo científico publicado en 2020

Glial and neuroinflammatory targets for treating substance use disorders

artículo científico publicado en 2017

Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances

artículo científico publicado en 2012

Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection

artículo científico publicado en 2013

How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies

artículo científico publicado en 2018

Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health

artículo científico publicado en 2012

Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder

artículo científico publicado en 2020

Naloxone-Induced Withdrawal in Individuals With and Without Fentanyl-Positive Urine Samples

scientific article published on 29 November 2019

Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin users

artículo científico publicado en 2015

No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone

artículo científico publicado en 2017

Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study

scientific article published on 15 April 2020

Opioid-Like Effects of the Neurokinin 1 Antagonist Aprepitant in Patients Maintained on and Briefly Withdrawn from Methadone ⬇️

artículo científico publicado el 1 de marzo de 2013

Oxycodone abuse in New York City: characteristics of intravenous and intranasal users

artículo científico publicado en 2011

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

artículo científico publicado en 2017

Polydrug abuse: A review of opioid and benzodiazepine combination use ⬇️

artículo científico publicado el 2 de agosto de 2012

Potential of Glial Cell Modulators in the Management of Substance Use Disorders

scientific article published on 04 April 2020

Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder

artículo científico publicado en 2016

Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

artículo científico publicado en 2013

Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms

artículo científico publicado en 2015

Sex differences among opioid-abusing patients with chronic pain in a clinical trial

artículo científico publicado en 2015

Strain-dependent sex differences in the effects of alcohol on cocaine-induced taste aversions

artículo científico publicado en 2006

The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City

artículo científico publicado en 2020

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

artículo científico publicado en 2018

The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity

artículo científico publicado en 2020

The effects of cocaine, alcohol and cocaine/alcohol combinations in conditioned taste aversion learning

artículo científico publicado en 2005

The effects of heroin administration and drug cues on impulsivity

artículo científico publicado en 2016

The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers

artículo científico publicado en 2015

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

artículo científico publicado en 2015

The pharmacogenetics of alcohol use disorder

artículo científico publicado en 2015

The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users

artículo científico publicado en 2014

The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone ⬇️

artículo científico publicado el 27 de octubre de 2010

Lista de obras de

A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers

A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City

A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior

A review of human drug self-administration procedures ⬇️

A review of pharmacogenetic studies of substance-related disorders

Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers

Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone

Can Naloxone Be Used to Treat Synthetic Cannabinoid Overdose?

Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal

Chronic pain and opioid abuse: Factors associated with health-related quality of life

Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts

Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.

Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers

Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers

Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder

Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis

Glial and neuroinflammatory targets for treating substance use disorders

Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances

Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection

How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies

Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health

Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder

Naloxone-Induced Withdrawal in Individuals With and Without Fentanyl-Positive Urine Samples

Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin users

No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone

Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study

Opioid-Like Effects of the Neurokinin 1 Antagonist Aprepitant in Patients Maintained on and Briefly Withdrawn from Methadone ⬇️

Oxycodone abuse in New York City: characteristics of intravenous and intranasal users

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Polydrug abuse: A review of opioid and benzodiazepine combination use ⬇️

Potential of Glial Cell Modulators in the Management of Substance Use Disorders

Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder

Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms

Sex differences among opioid-abusing patients with chronic pain in a clinical trial

Strain-dependent sex differences in the effects of alcohol on cocaine-induced taste aversions

The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity

The effects of cocaine, alcohol and cocaine/alcohol combinations in conditioned taste aversion learning

The effects of heroin administration and drug cues on impulsivity

The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

The pharmacogenetics of alcohol use disorder

The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users

The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone ⬇️